FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Vincristine Sulfate Injection, USP (Preservative-Free)
Status: Currently in Shortage
»Date first posted: 10/16/2019
»Therapeutic Categories: Oncology

Expand all

Hospira, Inc. (Revised 11/15/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL Single Dose Glass Fliptop Vial (NDC 61703-0309-06) Next Delivery: December 2019; Estimated Recovery: January 2020 Shortage per manufacturer: Manufacturing delay. Late October deliveries received. Product available to order and being released for direct shipment to health care providers to meet patient needs. Please contact Pfizer Supply Continuity Team between 7:00am – 6:00pm CT at 1-844-646-4398 (select option 1 [Customer], then option 3 [Supply Continuity Team]), for additional support.

Dear Customer Letter

Demand increase for the drug
2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 61703-0309-16) Next Delivery: November 2019; Estimated Recovery: December 2019 Shortage per manufacturer: Manufacturing delay. Late October deliveries received. Product available to order and being released for direct shipment to health care providers to meet patient needs. Please contact Pfizer Supply Continuity Team between 7:00am – 6:00pm CT at 1-844-646-4398 (select option 1 [Customer], then option 3 [Supply Continuity Team]), for additional support.

Dear Customer Letter

Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English